Your browser doesn't support javascript.
loading
Molecular hydrogen: a preventive and therapeutic medical gas for various diseases.
Ge, Li; Yang, Ming; Yang, Na-Na; Yin, Xin-Xin; Song, Wen-Gang.
Affiliation
  • Ge L; Department of Histology and Embryology, School of Basic Medical Sciences, Taishan Medical University, Tai-an City 271000, Shandong Province, PR China.
  • Yang M; Department of Clinical Medicine, Taishan Medical University, Tai-an City 271000, Shandong Province, PR China.
  • Yang NN; Key Laboratory of Atherosclerosis in Universities of Shandong, Taishan Medical University, Institute of Atherosclerosis, Taishan Medical University, Tai-an City 271000, Shandong Province, PR China.
  • Yin XX; Department of Clinical Medicine, Taishan Medical University, Tai-an City 271000, Shandong Province, PR China.
  • Song WG; Department of medical immunology, School of Basic Medical Sciences, Taishan Medical University, Tai-an City 271000, Shandong Province, PR China.
Oncotarget ; 8(60): 102653-102673, 2017 Nov 24.
Article in En | MEDLINE | ID: mdl-29254278
Since the 2007 discovery that molecular hydrogen (H2) has selective antioxidant properties, multiple studies have shown that H2 has beneficial effects in diverse animal models and human disease. This review discusses H2 biological effects and potential mechanisms of action in various diseases, including metabolic syndrome, organ injury, and cancer; describes effective H2 delivery approaches; and summarizes recent progress toward H2 applications in human medicine. We also discuss remaining questions in H2 therapy, and conclude with an appeal for a greater role for H2 in the prevention and treatment of human ailments that are currently major global health burdens. This review makes a case for supporting hydrogen medicine in human disease prevention and therapy.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Oncotarget Year: 2017 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Oncotarget Year: 2017 Document type: Article Country of publication: